Nicole Hsu

Nicole Hsu has extensive work experience in the field of regulatory affairs. Nicole currently holds the position of Vice President of Regulatory Affairs at Obsidian Therapeutics. Prior to this role, they served as the Senior Director of Regulatory Affairs at Elicio Therapeutics from August 2020 to August 2021. Before that, they worked as the Director of Regulatory Affairs at Aadi Bioscience from January 2019 to August 2020. Nicole has also held roles at Atara Biotherapeutics, Inc. as an Associate Director of Regulatory Affairs from January 2017 to January 2019 and as a Senior Manager of Regulatory Affairs from April 2015 to January 2017. Nicole has experience at Amgen as a Manager of Regulatory Affairs from March 2015 to April 2015 and as a Senior Associate of Regulatory Affairs from April 2012 to March 2015. Additionally, Nicole has worked as a Regulatory Affairs Graduate Intern at Medtronic in the Diabetes division from October 2011 to January 2012, and at Amgen in the Oncology division from June 2011 to August 2011. Nicole began their career as a Retail Pharmacist at Rxrelief from August 2005 to August 2009.

Nicole Hsu holds a Master of Science (MSc) degree in Regulatory Science from the University of Southern California, which they obtained from 2010 to 2012. Prior to that, they completed their Bachelor of Science in Pharmacy (B.ScPhm) from the University of Toronto's Faculty of Pharmacy, from 2001 to 2005.